4.7 Article

Diversity in genomic organisation, developmental regulation and distribution of the murine PR72/B subunits of protein phosphatase 2A

期刊

BMC GENOMICS
卷 9, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2164-9-393

关键词

-

资金

  1. Flemish government
  2. Belgian Science Policy
  3. 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'
  4. K.U. Leuven Research

向作者/读者索取更多资源

Background: Protein phosphatase 2A (PP2A) is a serine/threonine-specific phosphatase displaying vital functions in growth and development through its role in various signalling pathways. PP2A holoenzymes comprise a core dimer composed of a catalytic C and a structural A subunit, which can associate with a variable B-type subunit. The importance of the B-type subunits for PP2A regulation cannot be overestimated as they determine holoenzyme localisation, activity and substrate specificity. Three B-type subunit families have been identified: PR55/B, PR61/B' and PR72/B '', of which the latter is currently the least characterised. Results: We deduced the sequences and genomic organisation of the different murine PR72/B '' isoforms: three genes encode nine isoforms, five of which are abundantly expressed and give rise to genuine PP2A subunits. Thereby, one novel subunit was identified. Using Northern blotting, we examined the tissue-specific and developmental expression of these subunits. All subunits are highly expressed in heart, suggesting an important cardiac function. Immunohistochemical analysis revealed a striated expression pattern of PR72 and PR130 in heart and skeletal muscle, but not in bladder smooth muscle. The subcellular localisation and cell cycle regulatory ability of several PR72/B '' isoforms were determined, demonstrating differences as well as similarities. Conclusion: In contrast to PR55/B and PR61/B', the PR72/B '' family seems evolutionary more divergent, as only two of the murine genes have a human orthologue. We have integrated these results in a more consistent nomenclature of both human and murine PR72/B '' genes and their transcripts/proteins. Our results provide a platform for the future generation of PR72/B '' knockout mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis

Ievgenia Pastushenko, Federico Mauri, Yura Song, Florian de Cock, Bob Meeusen, Benjamin Swedlund, Francis Impens, Delphi Van Haver, Matthieu Opitz, Manuel Thery, Yacine Bareche, Gaelle Lapouge, Marjorie Vermeersch, Yves-Remi Van Eycke, Cedric Balsat, Christine Decaestecker, Youri Sokolow, Sergio Hassid, Alicia Perez-Bustillo, Beatriz Agreda-Moreno, Luis Rios-Buceta, Pedro Jaen, Pedro Redondo, Ramon Sieira-Gil, Jose F. Millan-Cayetano, Onofre Sanmatrtin, Nicky D'Haene, Virginie Moers, Milena Rozzi, Jeremy Blondeau, Sophie Lemaire, Samuel Scozzaro, Veerle Janssens, Magdalena De Troya, Christine Dubois, David Perez-Morga, Isabelle Salmon, Christos Sotiriou, Francoise Helmbacher, Cedric Blanpain

Summary: This study reveals that mutation of the FAT1 gene promotes tumor initiation, progression, invasiveness, stemness, and metastasis. Loss of function of FAT1 activates a CAMK2-CD44-SRC axis while inactivates EZH2, playing important roles in the expression of YAP1 and ZEB1.

NATURE (2021)

Review Biochemistry & Molecular Biology

Protein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease

Iris Verbinnen, Pieter Vaneynde, Sara Reynhout, Lisa Lenaerts, Rita Derua, Gunnar Houge, Veerle Janssens

Summary: In this review, the authors examine the impact of PP2A gene mutations on neurodevelopmental disorders and intellectual disability, with a focus on PPP2CA, PPP2R1A, and PPP2R5D. They provide insights into how these mutations affect PP2A structure, substrate specificity, and potential function in neurobiology and brain development.

BIOCHEMICAL SOCIETY TRANSACTIONS (2021)

Article Oncology

PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition

Bob Meeusen, Emanuela Elsa Cortesi, Judit Domenech Omella, Anna Sablina, Juan-Jose Ventura, Veerle Janssens

Summary: This study found that the loss of PP2A activator PTPA in KRAS-mutant lung adenocarcinomas is associated with poorer overall survival, increased cell growth, and accelerated tumor formation. Additionally, the depletion of PPP2R4 induced resistance against MEK inhibitor but sensitized cells to mTOR inhibitor, highlighting its clinical relevance in NSCLC etiology and kinase inhibitor response.

CANCER LETTERS (2021)

Article Cell Biology

Increased LGR6 Expression Sustains Long-Term Wnt Activation and Acquisition of Senescence in Epithelial Progenitors in Chronic Lung Diseases

Emanuela E. Cortesi, Bob Meeusen, Arno Vanstapel, Stijn E. Verleden, Bart M. Vanaudenaerde, Wim A. Wuyts, Wim Janssens, Veerle Janssens, Tania Roskams, Juan-Jose Ventura

Summary: Research indicates an elevated expression of LGR6 in abnormal lung epithelial progenitors in chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), with an increase in senescence-associated markers in these cells. Through chronic activation of the Wnt/beta-catenin pathway, LGR6 mediates the impairment and exhaustion of epithelial progenitors in both diseases.
Article Genetics & Heredity

Clinical, neuroimaging and molecular characteristics of PPP2R5D-related neurodevelopmental disorders: an expanded series with functional characterisation and genotype-phenotype analysis

Nora Oyama, Pieter Vaneynde, Sara Reynhout, Emily M. Pao, Andrew Timms, Xiao Fan, Kimberly Foss, Rita Derua, Veerle Janssens, Wendy Chung, Ghayda M. Mirzaa

Summary: This study delineates the common features of PPP2R5D-related neurodevelopmental disorders, expands the clinical and molecular spectrum, and identifies genotype-phenotype correlations.

JOURNAL OF MEDICAL GENETICS (2023)

Review Cell Biology

The role of serine/threonine phosphatases in human development: Evidence from congenital disorders

Pieter Vaneynde, Iris Verbinnen, Veerle Janssens

Summary: Reversible protein phosphorylation is a fundamental regulatory mechanism in eukaryotic cell and organismal physiology. Mutations in serine/threonine protein phosphatases (PSP) have been found to be associated with congenital diseases, most of which are characterized by brain-specific abnormalities. Understanding the pathogenic mechanisms of these diseases and identifying downstream targets and effectors could potentially lead to new therapeutic approaches.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Cell Biology

Clinical and molecular characteristics of a novel rare de novo variant in PPP2CA in a patient with a developmental disorder, autism, and epilepsy

Iris Verbinnen, Sara S. S. Procknow, Lisa Lenaerts, Sara Reynhout, Aujan Mehregan, Chris Ulens, Veerle Janssens, Katherine A. A. King

Summary: PP2A-related (neuro) developmental disorders are genetic diseases caused by genetic alterations in the genes encoding subunits of type 2A protein phosphatases. This study reports a case of PPP2CA-affected individual with a novel de novo missense variant, and evaluates its pathogenicity. Clinically, the patient presented with developmental delay, dysmorphic facial features, seizures, and autistic behaviors. This study reveals a milder manifestation of clinical and molecular spectrum in PPP2CA cases.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Chemistry, Medicinal

C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer?s disease targeting tauopathies

Raquel L. Arribas, Lucia Viejo, Isaac Bravo, Minerva Martinez, Eva Ramos, Alejandro Romero, Eva M. Garcia-Frutos, Veerle Janssens, Carmen Montiel, Cristobal de los Rios

Summary: Protein phosphatase 2A (PP2A) plays a crucial role in cellular processes and its deficiency is associated with severe pathologies. In Alzheimer's disease, the hyperphosphorylation of tau protein is linked to the depression of PP2A activity. Researchers have designed new ligands to prevent PP2A inhibition, with compound 10 showing the most promising outcomes.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Medicine, Research & Experimental

Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality

Jos van Pelt, Bob Meeusen, Rita Derua, Liesbeth Guffens, Eric Van Cutsem, Veerle Janssens, Chris Verslype

Summary: Pancreatic ductal adenocarcinoma (PDAC) has a low survival and little therapeutic advancements are expected. Epithelial-to-Mesenchymal transition (EMT) and Protein Phosphatase Type 2A (PP2A) play a role in aggressive PDAC. This study investigates the relationship between PP2A expression signature and EMT, and explores treatment implications.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Article Multidisciplinary Sciences

Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A

Karolina Pavic, Nikhil Gupta, Judit Domenech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A. Maatta, Nico Hofflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Abankwa, Maja Kohn, Vesa P. Hytonen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck

Summary: This study reveals the molecular level details and structural mechanisms of PP2A-B56 alpha inhibition by the oncoprotein CIP2A. CIP2A displaces the PP2A-A subunit and forms a pseudotrimer, blocking the B56 alpha substrate binding site and stabilizing CIP2A protein.

NATURE COMMUNICATIONS (2023)

Article Oncology

A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d

Judit Domenech Omella, Emanuela E. Cortesi, Iris Verbinnen, Michiel Remmerie, Hanghang Wu, Francisco J. Cubero, Tania Roskams, Veerle Janssens

Summary: The deletion of Ppp2r5d gene accelerates the development of hepatocellular carcinoma (HCC) in a mouse model of DEN-induced hepatocarcinogenesis, suggesting its tumor-suppressive function. The deletion of Ppp2r5d also leads to the development of HCC and combined hepatocellular-cholangiocarcinoma (cHCC-CCA), and may regulate its own expression to restrict tumor growth.

CANCERS (2023)

Editorial Material Cell Biology

Editorial: Deciphering the etiology of rare genetic disorders associated with protein phosphatases

Veerle Janssens, Brian E. Wadzinski, Chenchen Li, Richard E. Honkanen

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

Molecular insights into the tumour suppressor role of Protein Phosphatase 2A B56 delta complex in human liver, and its clinically relevant inhibition by cancerous inhibitor of PP2A

Judit Domenech Omella, Bob Meeusen, Emanuela Cortesi, Karen Zwaenepoel, Rita Derua, Chris Verslype, Patrick Pauwels, Jukka Westermarck, Tania Roskams, Jos van Pelt, Veerle Janssens

JOURNAL OF HEPATOLOGY (2022)

Article Nutrition & Dietetics

Zinc deficiency leads to reduced interleukin-2 production by active gene silencing due to enhanced CREMa expression in T cells

Veronika Kloubert, Inga Wessels, Jana Wolf, Karoline Blaabjerg, Veerle Janssens, Jan Hapala, Wolfgang Wagner, Lothar Rink

Summary: The study revealed that zinc deficiency leads to reduced IL-2 expression in T cells due to enhanced PP2A and HDAC1 activity, and a molecular link through the transcription factor CREMa was uncovered in connecting zinc deficiency with this decreased IL-2 production.

CLINICAL NUTRITION (2021)

Article Genetics & Heredity

The broad phenotypic spectrum of PPP2R1A-related neurodevelopmental disorders correlates with the degree of biochemical dysfunction

Lisa Lenaerts, Sara Reynhout, Iris Verbinnen, Frederic Laumonnier, Annick Toutain, Frederique Bonnet-Brilhault, Yana Hoorne, Shelagh Joss, Anna K. Chassevent, Constance Smith-Hicks, Bart Loeys, Pascal Joset, Katharina Steindl, Anita Rauch, Sarju G. Mehta, Wendy K. Chung, Koenraad Devriendt, Susan E. Holder, Tamison Jewett, Lauren M. Baldwin, William G. Wilson, Shelley Towner, Siddharth Srivastava, Hannah F. Johnson, Cornelia Daumer-Haas, Martina Baethmann, Anna Ruiz, Elisabeth Gabau, Vani Jain, Vinod Varghese, Ali Al-Beshri, Stephen Fulton, Oded Wechsberg, Naama Orenstein, Katrina Prescott, Anne-Marie Childs, Laurence Faivre, Sebastien Moutton, Jennifer A. Sullivan, Vandana Shashi, Suzanne M. Koudijs, Malou Heijligers, Emma Kivuva, Amy McTague, Alison Male, Yvette van Ierland, Barbara Plecko, Isabelle Maystadt, Rizwan Hamid, Vickie L. Hannig, Gunnar Houge, Veerle Janssens

Summary: We significantly expand the phenotypic spectrum of PPP2R1A-related NDD, revealing a broader clinical presentation of the patients and that the functional consequences of the variants are more diverse than previously reported.

GENETICS IN MEDICINE (2021)

暂无数据